ACETAMINOPHEN AND OTHER RISK-FACTORS FOR EXCESSIVE WARFARIN ANTICOAGULATION

Citation
Em. Hylek et al., ACETAMINOPHEN AND OTHER RISK-FACTORS FOR EXCESSIVE WARFARIN ANTICOAGULATION, JAMA, the journal of the American Medical Association, 279(9), 1998, pp. 657-662
Citations number
44
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00987484
Volume
279
Issue
9
Year of publication
1998
Pages
657 - 662
Database
ISI
SICI code
0098-7484(1998)279:9<657:AAORFE>2.0.ZU;2-8
Abstract
Context.-Warfarin is highly effective in preventing thromboembolism, b ut increases the risk of hemorrhage, particularly at an international normalized ratio (INR) greater than 4.0. Identifying causes of excessi ve anticoagulation in clinical practice could help target patients at risk for elevated INRs. Objective.-To determine causes of INRs greater than 6.0 in a clinical practice setting. Design.-Case-control study. Setting.-Outpatient anticoagulant therapy unit, Patients.-Outpatients followed up prospectively from April 1995 to March 1996 who had been t aking warfarin for more than 1 month, had a target INR of 2.0 to 3.0, and were able to be interviewed within 24 hours of their reported INR. Case patients had INRs greater than 6.0; controls were randomly selec ted from patients having INRs between 1.7 and 3.3. Main Outcome Measur es.-Factors associated with INRs greater than 6.0, including medicatio n use, recent diet, illness, alcohol consumption, and actual warfarin use. Results.-A total of 93 cases and 196 controls were interviewed; t hey did not differ in age, indication for warfarin, length of therapy, warfarin dose, number of prescription medications, or previous INR or long-term INR variability. Acetaminophen ingestion was independently associated in a dose-dependent manner with having an INR greater than 6.0 (P for trend <.001). For the highest-dose category of acetaminophe n intake, 9100 mg/wk or more, the odds of having an INR greater than 6 .0 were increased 10-fold (95% confidence interval [CI], 2.6-37.9). Ot her factors independently associated with an INR greater than 6.0 were new medication known to potentiate warfarin (odds ratio [OR], 8.5; 95 % CI, 2.9-24.7), advanced malignancy (OR, 16.4; 95% CI, 2.4-111.0), re cent diarrheal illness (OR, 3.5; 95% CI, 1.4-8.6), decreased oral inta ke (OR, 3.6; 95% CI, 1.3-9.7), and taking more warfarin than prescribe d (OR, 8.1; 95% CI, 2.2-30.0). Higher vitamin K intake (OR, 0.7; 95% C I, 0.5-0.9) and habitual alcohol consumption of from 1 drink every oth er day to 2 drinks a day (OR, 0.2; 95% CI, 0.1-0.7) were associated wi th decreased risk. Conclusions.-These data suggest that acetaminophen is an underrecognized cause of overanticoagulation in the outpatient s etting. Several other clinically important risk factors were identifie d. Increased monitoring of INR values when such risk factors are prese nt or modification of the risk factors themselves should reduce the fr equency of dangerously high levels of anticoagulation.